Roger Garceau's Net Worth
$6.54 Million
Who is Roger Garceau?
Roger Garceau has an estimated net worth of $6.54 Million. This is based on reported shares across multiple companies, which include Protara Therapeutics, Inc., Entera Bio Ltd., and NPS PHARMACEUTICALS INC.
SEC CIK
Roger Garceau's CIK is 0001451767
Past Insider Trading and Trends
2013 was Roger Garceau's most active year for acquiring shares with 7 total transactions. Roger Garceau's most active month to acquire stocks was the month of January. 2015 was Roger Garceau's most active year for disposing of shares, totalling 16 transactions. Roger Garceau's most active month to dispose stocks was the month of January. 2012 saw Roger Garceau paying a total of $840,937.50 for 345,725 shares, this is the most they've acquired in one year. In 2013 Roger Garceau cashed out on 262,789 shares for a total of $2,895,693.49, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Protara Therapeutics, Inc. (TARA) Snapshot price: $1.9505
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
∞
| 33K |
—
|
—
| 33K |
Jan 9 - Jan 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Entera Bio Ltd. (ENTX) Snapshot price: $1.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NPS PHARMACEUTICALS INC No price found
SVP & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -43.35K |
$46.00 | -$1,994,054.00 |
0
|
Feb 21
| |||
Form 4
| +64.95% | 17.07K |
$45.86 | -$571,546.50 | 43.35K |
Feb 7 - Feb 13
| |||
Form 4
| -20.97% | -11.00K |
—
|
—
| 41.45K |
Feb 10
| |||
Form 4
| -22.68% | -15.38K |
$45.88 | -$705,817.92 | 52.45K |
Feb 5
| |||
Form 4
| +10.79% | 6.61K |
$38.30 | -$150,212.60 | 67.83K |
Feb 12 - Feb 13
| |||
Form 4
| +19.05% | 9.8K |
$35.13 | -$188,683.23 | 61.22K |
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
$14.96 | -$2,248,186.47 | 64.15K |
Scheduled
|
Aug 30
| ||
Form 4
| +38.40% | 17.8K |
$8.01 | -$77,721.03 | 64.15K |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +26.05% | 9.58K |
$8.61 | -$48,095.46 | 46.35K |
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
$7.75 | -$496,181.25 |
0
|
Scheduled
|
Oct 3
| ||
Form 4
|
∞
| 45.5K |
—
|
—
| 45.5K |
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |